The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 26, 2019

Filed:

Aug. 23, 2016
Applicant:

The Regents of the University of California, Oakland, CA (US);

Inventors:

David V. Schaffer, Danville, CA (US);

Ryan R. Klimczak, San Francisco, CA (US);

James T. Koerber, San Francisco, CA (US);

John G. Flannery, Berkeley, CA (US);

Deniz Dalkara Mourot, Berkeley, CA (US);

Meike Visel, El Cerrito, CA (US);

Leah C. T. Byrne, Berkeley, CA (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/70 (2006.01); A61K 48/00 (2006.01); C07K 14/005 (2006.01); C12N 15/86 (2006.01); C12N 7/00 (2006.01); G01N 33/50 (2006.01); A61K 9/00 (2006.01); A61K 38/17 (2006.01); C12N 15/113 (2010.01); C12N 15/115 (2010.01);
U.S. Cl.
CPC ...
C12Q 1/701 (2013.01); A61K 9/0019 (2013.01); A61K 9/0048 (2013.01); A61K 38/1709 (2013.01); A61K 48/0008 (2013.01); A61K 48/0025 (2013.01); A61K 48/0075 (2013.01); C07K 14/005 (2013.01); C12N 7/00 (2013.01); C12N 15/113 (2013.01); C12N 15/115 (2013.01); C12N 15/86 (2013.01); C12Q 1/70 (2013.01); G01N 33/5008 (2013.01); G01N 33/5058 (2013.01); C07K 2319/33 (2013.01); C12N 2310/14 (2013.01); C12N 2310/16 (2013.01); C12N 2320/32 (2013.01); C12N 2750/14021 (2013.01); C12N 2750/14121 (2013.01); C12N 2750/14122 (2013.01); C12N 2750/14142 (2013.01); C12N 2750/14143 (2013.01); C12N 2750/14145 (2013.01); C12N 2750/14152 (2013.01); C12N 2810/40 (2013.01); C12Q 2600/158 (2013.01); C12Q 2600/16 (2013.01);
Abstract

The present disclosure provides adeno-associated virus (AAV) virions with altered capsid protein, where the AAV virions exhibit greater infectivity of retinal cells, when administered via intravitreal injection, compared to wild-type AAV. The present disclosure further provides methods of delivering a gene product to a retinal cell in an individual, and methods of treating ocular disease.


Find Patent Forward Citations

Loading…